SCR-LIP-000765 · Claim · machine-readable JSON →
Reliance on body mass index and the absence of validated objective criteria or biomarkers are reported to hinder recognition of lipedema.
General proposition consolidated from 5 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 6 source(s) · by Amato
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (6)
- Ultrasound criteria for lipedema diagnosis — Amato et al. (2021) ✓ verified — consistent · cross sectional · n=89 · 2021 · risk of bias: moderate · reading confidence: high
In 89 participants, 81% of the lipedema group were overweight or obese by BMI alone; pretibial ultrasound thickness gave AUC about 0.91, cut-off 11.7 mm (sensitivity 0.77-0.79, specificity 0.92-0.96).
81% of lipedema group overweight/obese by BMI alone - Amato ACM, 2021 unverified — consistent · expert opinion · 2022 · risk of bias: high
Expert book chapter arguing that defining obesity by BMI alone disregards fat distribution, so lipedema is missed when workup stops at an obesity diagnosis.
book chapter on overdiagnosis - Lipedema—Pathogenesis, Diagnosis, and Treatment Options — Kruppa et al. (2020) ✓ verified — consistent · review · 2020 · reading confidence: high
“O diagnóstico do lipedema permanece desafiador devido à apresentação heterogênea e à ausência de instrumentos objetivos de caracterização.”
Review: lipedema often unrecognised despite estimated 10% prevalence; diagnosis relies on clinical grounds because of heterogeneous presentation and no objective characterisation instruments.
This selective literature review directly addresses underdiagnosis of lipedema and the absence of objective screening/diagnostic tools, supporting the affirmative direction of the question, though it does not evaluate a specific screening t - Editorial for “Subcutaneous Adipose Tissue Edema in Lipedema Revealed by Noninvasive 3T Magnetic Resonance Lymphangiography” — Wang (2023) ✓ verified — consistent · review · 2023 · reading confidence: high
“O editorial enfatiza a carência de biomarcadores confiáveis e eficazes do lipedema e o papel potencial das medidas de RM do conteúdo de gordura tecidual no diagnóstico diferencial entre lipedema e obesidade.”
Editorial emphasising the lack of reliable lipedema biomarkers and the potential of MR fat and edema measures to aid differential diagnosis from obesity, with small samples limiting evidence.
Editorial commentary discussing the need for diagnostic biomarkers and a potential MR imaging tool for identifying lipedema, which contextually relates to underdiagnosis and detection/screening, but it is not a primary study quantifying und - Lipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) ✓ verified — consistent · review · 2026 · reading confidence: high
“addressing the persistent underdiagnosis and misdiagnosis of the condition”
Review addressing persistent underdiagnosis; ultrasound cut-offs (pretibial 11.7 mm, sensitivity 0.77-0.79) and DXA leg-fat ratio 0.384 proposed as auxiliary aids, not yet externally validated.
The review explicitly addresses persistent underdiagnosis and describes imaging screening/diagnostic aids with cutoffs and performance, supporting the affirmative but noting the ultrasound cutoffs are not yet externally validated (a caveat) - Dor crônica e biomarcadores inflamatórios em mulheres com obesidade: Impacto dos Fenótipos Adiposos e Lipedema — Silva et al. (2026) ✓ verified — consistent · review · 2026 · reading confidence: moderate
“Fenótipo ginoide pode simular lipedema — ausência de triagem sistemática compromete a interpretabilidade dos dados de dor-inflamação”
Narrative review: gynoid obesity phenotype can mimic lipedema, and lack of systematic lipedema screening in obesity studies compromises interpretation of pain-inflammation data.
The article is a narrative review (not a systematic review or meta-analysis) that explicitly calls for systematic lipedema screening to avoid misclassification, directly supporting the premise that lipedema is underdiagnosed and that screen
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000037